Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

A cyclase III Inhibitors

Santa Cruz Biotechnology now offers a broad range of A cyclase III Inhibitors for use in various applications. A cyclase III inhibitors are specialized compounds that specifically target and inhibit adenylyl cyclase type III, an enzyme involved in the conversion of ATP to cyclic AMP (cAMP) in response to extracellular signals. This enzyme plays a critical role in various cellular processes, including the regulation of sensory functions such as olfaction and taste, as well as in neural signaling pathways. In scientific research, A cyclase III inhibitors are essential for studying the intricate mechanisms of cAMP-mediated signal transduction and its impact on cellular and physiological functions. Researchers use these inhibitors to dissect the specific roles of adenylyl cyclase III in different biological systems, exploring how its activity affects sensory perception, neuronal communication, and other cAMP-dependent processes. By modulating the activity of adenylyl cyclase III, scientists can gain insights into the regulatory networks that control these pathways and investigate the broader implications of altered cAMP signaling. The availability of high-purity A cyclase III inhibitors from Santa Cruz Biotechnology ensures that experiments are conducted with precision and reproducibility, yielding reliable data critical for advancing scientific knowledge. By offering a comprehensive selection of these inhibitors, Santa Cruz Biotechnology supports the scientific community in developing new experimental models, uncovering novel insights into cellular signaling, and facilitating innovative research approaches. View detailed information on our available A cyclase III Inhibitors by clicking on the product name.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Adenylyl Cyclase Type V Inhibitor, NKY80

299442-43-6sc-221217
sc-221217A
5 mg
25 mg
$124.00
$431.00
(0)

Adenylyl Cyclase Type V Inhibitor, NKY80, selectively targets adenylate cyclase III, disrupting its catalytic function. This compound exhibits a unique affinity for specific allosteric sites, leading to altered enzyme conformation and reduced cyclic AMP production. Its kinetic profile reveals a competitive inhibition mechanism, effectively modulating downstream signaling pathways. The inhibitor's distinct molecular interactions highlight its role in fine-tuning cellular responses, emphasizing its significance in biochemical regulation.